Product Images Doxazosin

This text presents the results of three different studies evaluating the efficacy of doxazosin in treating benign prostatic hyperplasia (BPH). The studies measured the maximum flow rate (in mL/sec) and symptom scores of patients before and after treatment with either doxazosin or a placebo. Two of the studies titrated patients to a fixed maximum dose of doxazosin, while one titrated to the maximum dose of 8 ng. The results showed that doxazosin improved maximum flow rate and symptom scores in comparison to placebo, with statistically significant findings in some instances. The studies used different scoring systems for symptom evaluation.*

This appears to be a table or graph displaying data related to a study comparing the effects of a treatment on symptoms and urinary flow rate in a group of 47 individuals over the course of several weeks. The results show changes from baseline measurements, with statistical significance noted for some comparisons. The treatment appears to involve titration of doxazosin up to a maximum dose of 8 mg.*

Doxazosin tablets are a medication that is available in a pack of 100 tablets manufactured by GRS Laboratories. However, no specific information can be understood due to the incomplete and unclear text.*